Human Technologies (5621) Fundamentals 2026 — P/E 15.3x, Revenue Analysis | SniperIQ
Human Technologies (5621) is a JP-listed Technology company in Software - Application with a market capitalization of ¥15.5B, trading at ¥1620.00 on the JPX. This SniperIQ fundamentals page covers Human Technologies's valuation (P/E 15.3x, P/B 2.9x), profitability (net margin 13.6%), revenue (¥7.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Human Technologies's market cap?
Human Technologies (5621) has a market capitalization of approximately ¥15.5B, trading at ¥1620.00 on the JPX. Market cap moves with the live share price.
What is Human Technologies's P/E ratio?
Human Technologies's trailing twelve-month P/E ratio is 15.3x, with a price-to-book (P/B) of 2.9x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.
How profitable is Human Technologies?
Human Technologies runs a net profit margin of 13.6%, a gross margin of 64.7%, and an operating margin of 18.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Human Technologies generate?
Human Technologies reported revenue of ¥7.5B for fiscal year 2025, with net income of ¥1.0B and earnings per share (EPS) of 105.94. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Human Technologies pay a dividend?
Human Technologies offers a trailing dividend yield of about 2.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Human Technologies financially healthy?
Human Technologies carries a debt-to-equity ratio of 0.00x and a current ratio of 3.89x, with a market beta of 0.75. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Human Technologies a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Human Technologies (5621) the key facts are: market cap ¥15.5B, P/E 15.3x, revenue ¥7.5B, 52-week range 1263-2683. Weigh valuation, profitability, growth, and balance-sheet strength against Technology peers and form your own view.
Track Human Technologies's full fundamentals live
Get Human Technologies's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.